337 related articles for article (PubMed ID: 20815175)
21. After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
Huber K; Superti-Furga G
Bioorg Med Chem; 2011 Jun; 19(12):3616-24. PubMed ID: 21306906
[TBL] [Abstract][Full Text] [Related]
22. Sirtuins (histone deacetylases III) in the cellular response to DNA damage--facts and hypotheses.
Kruszewski M; Szumiel I
DNA Repair (Amst); 2005 Nov; 4(11):1306-13. PubMed ID: 16084131
[TBL] [Abstract][Full Text] [Related]
23. Franklin H. Epstein Lecture: Sirtuins, aging, and medicine.
Guarente L
N Engl J Med; 2011 Jun; 364(23):2235-44. PubMed ID: 21651395
[No Abstract] [Full Text] [Related]
24. SIRTUIN 1: regulating the regulator.
Zschoernig B; Mahlknecht U
Biochem Biophys Res Commun; 2008 Nov; 376(2):251-5. PubMed ID: 18774777
[TBL] [Abstract][Full Text] [Related]
25. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 1.
Kelly G
Altern Med Rev; 2010 Sep; 15(3):245-63. PubMed ID: 21155626
[TBL] [Abstract][Full Text] [Related]
26. Vitamin B3 and sirtuin function.
Denu JM
Trends Biochem Sci; 2005 Sep; 30(9):479-83. PubMed ID: 16039130
[TBL] [Abstract][Full Text] [Related]
27. Salermide, a Sirtuin inhibitor with a strong cancer-specific proapoptotic effect.
Lara E; Mai A; Calvanese V; Altucci L; Lopez-Nieva P; Martinez-Chantar ML; Varela-Rey M; Rotili D; Nebbioso A; Ropero S; Montoya G; Oyarzabal J; Velasco S; Serrano M; Witt M; Villar-Garea A; Imhof A; Mato JM; Esteller M; Fraga MF
Oncogene; 2009 Feb; 28(6):781-91. PubMed ID: 19060927
[TBL] [Abstract][Full Text] [Related]
28. Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease.
Outeiro TF; Kontopoulos E; Altmann SM; Kufareva I; Strathearn KE; Amore AM; Volk CB; Maxwell MM; Rochet JC; McLean PJ; Young AB; Abagyan R; Feany MB; Hyman BT; Kazantsev AG
Science; 2007 Jul; 317(5837):516-9. PubMed ID: 17588900
[TBL] [Abstract][Full Text] [Related]
29. Function of sirtuins in biological tissues.
Shoba B; Lwin ZM; Ling LS; Bay BH; Yip GW; Kumar SD
Anat Rec (Hoboken); 2009 Apr; 292(4):536-43. PubMed ID: 19301279
[TBL] [Abstract][Full Text] [Related]
30. Sirtuin-independent effects of nicotinamide on lifespan extension from calorie restriction in yeast.
Tsuchiya M; Dang N; Kerr EO; Hu D; Steffen KK; Oakes JA; Kennedy BK; Kaeberlein M
Aging Cell; 2006 Dec; 5(6):505-14. PubMed ID: 17129213
[TBL] [Abstract][Full Text] [Related]
31. Bisnaphthalimidopropyl derivatives as inhibitors of Leishmania SIR2 related protein 1.
Tavares J; Ouaissi A; Kong Thoo Lin P; Loureiro I; Kaur S; Roy N; Cordeiro-da-Silva A
ChemMedChem; 2010 Jan; 5(1):140-7. PubMed ID: 19937668
[TBL] [Abstract][Full Text] [Related]
32. Sirtuins--novel therapeutic targets to treat age-associated diseases.
Lavu S; Boss O; Elliott PJ; Lambert PD
Nat Rev Drug Discov; 2008 Oct; 7(10):841-53. PubMed ID: 18827827
[TBL] [Abstract][Full Text] [Related]
33. A review of the sirtuin system, its clinical implications, and the potential role of dietary activators like resveratrol: part 2.
Kelly GS
Altern Med Rev; 2010 Dec; 15(4):313-28. PubMed ID: 21194247
[TBL] [Abstract][Full Text] [Related]
34. The role of sirtuins in aging and age-related diseases.
Wątroba M; Szukiewicz D
Adv Med Sci; 2016 Mar; 61(1):52-62. PubMed ID: 26521204
[TBL] [Abstract][Full Text] [Related]
35. Sirtuins: critical regulators at the crossroads between cancer and aging.
Saunders LR; Verdin E
Oncogene; 2007 Aug; 26(37):5489-504. PubMed ID: 17694089
[TBL] [Abstract][Full Text] [Related]
36. Aging and disease: connections to sirtuins.
Donmez G; Guarente L
Aging Cell; 2010 Apr; 9(2):285-90. PubMed ID: 20409078
[TBL] [Abstract][Full Text] [Related]
37. Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes.
Alcendor RR; Kirshenbaum LA; Imai S; Vatner SF; Sadoshima J
Circ Res; 2004 Nov; 95(10):971-80. PubMed ID: 15486319
[TBL] [Abstract][Full Text] [Related]
38. Mice share yeast's ageing system.
Ledford H
Nature; 2008 Nov; 456(7221):433. PubMed ID: 19037283
[No Abstract] [Full Text] [Related]
39. Involvement of sirtuins in life-span and aging related diseases.
Mahlknecht U; Zschoernig B
Adv Exp Med Biol; 2012; 739():252-61. PubMed ID: 22399407
[TBL] [Abstract][Full Text] [Related]
40. Enhancing cell longevity for cosmetic application: a complementary approach.
Moreau M; Neveu M; Stéphan S; Noblesse E; Nizard C; Sadick NS; Schnebert S; Bonté F; Dumas M; Andre P; Perrier E
J Drugs Dermatol; 2007 Jun; 6(6 Suppl):s14-9. PubMed ID: 17691205
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
